Altimmune, Inc. financial data

Symbol
ALT on Nasdaq
Location
Gaithersburg, MD
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 06 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1799% % 28%
Debt-to-equity 18% % 62%
Return On Equity -49% % 24%
Return On Assets -42% % 29%
Operating Margin -230461% % 55%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 130,069,983 shares 69%
Common Stock, Shares, Outstanding 110,882,735 shares 53%
Entity Public Float $326,800,000 USD -30%
Common Stock, Value, Issued $11,000 USD 57%
Weighted Average Number of Shares Outstanding, Basic 88,104,132 shares 24%
Weighted Average Number of Shares Outstanding, Diluted 88,104,132 shares 24%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $41,000 USD 105%
Research and Development Expense $66,432,000 USD -19%
General and Administrative Expense $28,098,000 USD 34%
Operating Income (Loss) $94,489,000 USD 8.4%
Nonoperating Income (Expense) $5,715,000 USD -30%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $88,774,000 USD 6.6%
Income Tax Expense (Benefit) $681,000 USD
Net Income (Loss) Attributable to Parent $88,093,000 USD 7.3%
Earnings Per Share, Basic -1 USD/shares 25%
Earnings Per Share, Diluted -1 USD/shares 25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $43,760,000 USD 19%
Assets, Current $278,192,000 USD 103%
Property, Plant and Equipment, Net $312,000 USD -24%
Operating Lease, Right-of-Use Asset $1,425,000 USD -13%
Intangible Assets, Net (Excluding Goodwill) $0 USD
Other Assets, Noncurrent $1,425,000 USD -13%
Assets $279,929,000 USD 101%
Accounts Payable, Current $2,717,000 USD 1188%
Employee-related Liabilities, Current $4,676,000 USD 52%
Liabilities, Current $14,997,000 USD 43%
Operating Lease, Liability, Noncurrent $1,145,000 USD -18%
Other Liabilities, Noncurrent $5,753,000 USD 7.9%
Liabilities $55,037,000 USD 248%
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,928,000 USD 0.9%
Retained Earnings (Accumulated Deficit) $649,483,000 USD -16%
Stockholders' Equity Attributable to Parent $224,892,000 USD 82%
Liabilities and Equity $279,929,000 USD 101%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $16,840,000 USD -3%
Net Cash Provided by (Used in) Financing Activities $34,119,000 USD
Net Cash Provided by (Used in) Investing Activities $5,101,000 USD 87%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 110,882,735 shares 53%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $12,178,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $43,802,000 USD 18%
Deferred Tax Assets, Valuation Allowance $127,141,000 USD 19%
Deferred Tax Assets, Gross $127,610,000 USD 19%
Operating Lease, Liability $1,401,000 USD -17%
Depreciation $29,000 USD -73%
Lessee, Operating Lease, Liability, to be Paid $1,709,000 USD -20%
Property, Plant and Equipment, Gross $2,637,000 USD 0.42%
Operating Lease, Liability, Current $256,000 USD -8.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two $387,000 USD 2.9%
Lessee, Operating Lease, Liability, to be Paid, Year One $376,000 USD -11%
Operating Lease, Weighted Average Discount Rate, Percent 0.095 pure 0%
Deferred Income Tax Expense (Benefit) $681,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $308,000 USD -32%
Lessee, Operating Lease, Liability, to be Paid, Year Three $398,000 USD 2.8%
Deferred Tax Assets, Operating Loss Carryforwards $115,761,000 USD 79%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Unrecognized Tax Benefits $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four $410,000 USD 3%
Operating Lease, Payments $100,000 USD 0%
Additional Paid in Capital $879,292,000 USD 27%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $469,000 USD 4%
Share-based Payment Arrangement, Expense $16,076,000 USD 12%
Interest Expense $34,000 USD -50%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%